These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 31198190)
21. Generating Utilities for the Château-Santé Base: A Novel, Generic, and Patient-Centered Health-Outcome Measure. Zhang X; Vermeulen KM; Veeger NJGM; Jabrayilov R; Krabbe PFM Value Health; 2024 Oct; 27(10):1426-1435. PubMed ID: 38977185 [TBL] [Abstract][Full Text] [Related]
22. Development and validation of a new instrument to measure health-related quality of life in patients with psoriatic arthritis: the VITACORA-19. Torre-Alonso JC; Gratacós J; Rey-Rey JS; Valdazo de Diego JP; Urriticoechea-Arana A; Daudén E; Moreno M; Zarco-Montejo P; Collantes-Estévez E; Fernández-López JA J Rheumatol; 2014 Oct; 41(10):2008-17. PubMed ID: 25179846 [TBL] [Abstract][Full Text] [Related]
23. The Ostomy-Q: Development and Psychometric Validation of an Instrument to Evaluate Outcomes Associated with Ostomy Appliances. Nafees B; Rasmussen M; LLoyd A Ostomy Wound Manage; 2017 Jan; 63(1):12-22. PubMed ID: 28112646 [TBL] [Abstract][Full Text] [Related]
24. Critical review of generic and dermatology-specific health-related quality of life instruments. Both H; Essink-Bot ML; Busschbach J; Nijsten T J Invest Dermatol; 2007 Dec; 127(12):2726-39. PubMed ID: 17989733 [TBL] [Abstract][Full Text] [Related]
25. Validation of the Dutch version of the CDC core healthy days measures in a community sample. Toet J; Raat H; van Ameijden EJ Qual Life Res; 2006 Feb; 15(1):179-84. PubMed ID: 16411043 [TBL] [Abstract][Full Text] [Related]
26. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Whalley D; McKenna SP; Dewar AL; Erdman RA; Kohlmann T; Niero M; Cook SA; Crickx B; Herdman MJ; Frech F; Van Assche D Br J Dermatol; 2004 Feb; 150(2):274-83. PubMed ID: 14996098 [TBL] [Abstract][Full Text] [Related]
27. Estimating a Dutch Value Set for the Pediatric Preference-Based CHU9D Using a Discrete Choice Experiment with Duration. Rowen D; Mulhern B; Stevens K; Vermaire JH Value Health; 2018 Oct; 21(10):1234-1242. PubMed ID: 30314625 [TBL] [Abstract][Full Text] [Related]
28. Patient and public preferences for health states associated with AMD. Butt T; Dunbar HM; Morris S; Orr S; Rubin GS Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607 [TBL] [Abstract][Full Text] [Related]
30. The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning. Günther OH; Roick C; Angermeyer MC; König HH J Affect Disord; 2008 Jan; 105(1-3):81-91. PubMed ID: 17532051 [TBL] [Abstract][Full Text] [Related]
31. Developing a dementia-specific preference--based quality of life measure (AD-5D) in Australia: a valuation study protocol. Comans TA; Nguyen KH; Mulhern B; Corlis M; Li L; Welch A; Kurrle SE; Rowen D; Moyle W; Kularatna S; Ratcliffe J BMJ Open; 2018 Jan; 8(1):e018996. PubMed ID: 29358437 [TBL] [Abstract][Full Text] [Related]
32. The impact of rheumatoid arthritis on the burden of disease in urban China. Langley PC; Mu R; Wu M; Dong P; Tang B J Med Econ; 2011; 14(6):709-19. PubMed ID: 21899486 [TBL] [Abstract][Full Text] [Related]
33. [A preliminary validation of a new French instrument to assess quality of life for caregivers of patients suffering from schizophrenia]. Richieri R; Boyer L; Reine G; Loundou AD; Simeoni MC; Auquier P; Lançon C Encephale; 2011 Dec; 37(6):425-32. PubMed ID: 22137214 [TBL] [Abstract][Full Text] [Related]
34. Preference Weighting of Health State Values: What Difference Does It Make, and Why? Lamu AN; Gamst-Klaussen T; Olsen JA Value Health; 2017 Mar; 20(3):451-457. PubMed ID: 28292490 [TBL] [Abstract][Full Text] [Related]
35. Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life. Rowen D; Brazier J; Mukuria C; Keetharuth A; Risa Hole A; Tsuchiya A; Whyte S; Shackley P Med Decis Making; 2016 Feb; 36(2):210-22. PubMed ID: 26670663 [TBL] [Abstract][Full Text] [Related]
36. Development and evaluation of the quality of life instrument in chronic liver disease patients with minimal hepatic encephalopathy. Zhou YQ; Chen SY; Jiang LD; Guo CY; Shen ZY; Huang PX; Wang JY J Gastroenterol Hepatol; 2009 Mar; 24(3):408-15. PubMed ID: 19054261 [TBL] [Abstract][Full Text] [Related]
37. Estimating a preference-based index for a menopause specific health quality of life questionnaire. Brazier JE; Roberts J; Platts M; Zoellner YF Health Qual Life Outcomes; 2005 Mar; 3():13. PubMed ID: 15769294 [TBL] [Abstract][Full Text] [Related]
38. Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK. Swinburn P; Lloyd A; Boye KS; Edson-Heredia E; Bowman L; Janssen B Value Health; 2013 Dec; 16(8):1156-62. PubMed ID: 24326169 [TBL] [Abstract][Full Text] [Related]